Effect of valdecoxib pretreatment on pain and secondary hyperalgesia: a randomized controlled trial in healthy volunteers [ISRCTN05282752, NCT00260325

BMC Anesthesiology
David BurnsPiotr K Janicki

Abstract

Induction of the COX-2 isoenzyme appears to play a major role in the genesis of central sensitization after nociceptive stimulation. This study aimed to investigate the efficacy of a single, oral dose of the specific COX-2 inhibitor-valdecoxib in attenuating the central sensitization - induced secondary hyperalgesia in a heat/capsaicin pain model in healthy volunteers. The study was a randomized, double blind, placebo controlled, crossover, single dose efficacy trial using 20 healthy volunteers. Two hours following placebo or 40 mg, PO valdecoxib, participants underwent skin sensitization with heat/capsaicin, as well as supra-threshold pain and re-kindling measurements according to an established, validated pain model. Subjects rated pain intensity and unpleasantness on a visual analog scale and the area of secondary hyperalgesia was serially mapped. The area of secondary hyperalgesia produced after 40 mg of valdecoxib was no different than that after placebo. Furthermore, there were no significantly relevant differences when volunteers were treated with valdecoxib or placebo in relation to either cold- or hot pain threshold or the intensity of pain after supra-threshold, thermal pain stimulation. We demonstrated that a single,...Continue Reading

References

Aug 27, 1998·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·A R SantosG A De Freitas
Jun 25, 1999·Neuroreport·K L Petersen, M C Rowbotham
Jul 20, 2002·Anesthesiology·Jesper DirksJørgen B Dahl
Oct 3, 2002·Anesthesiology·James C EisenachDavid D Hood
Oct 10, 2002·Regional Anesthesia and Pain Medicine·Jeffrey S KroinKenneth J Tuman
May 27, 2003·Anesthesiology·Michal GranotEtan Z Zimmer
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Jesper DirksJørgen B Dahl
May 22, 2004·Journal of Clinical Pharmacy and Therapeutics·L-C ChenD M Ashcroft
Feb 1, 2005·Anesthesiology·Gregory DemboEvan D Kharasch

❮ Previous
Next ❯

Citations

May 21, 2016·British Journal of Clinical Pharmacology·Guido van AmerongenJustin L Hay
Oct 22, 2011·Expert Review of Neurotherapeutics·Lars Arendt-Nielsen, Hans Christian Hoeck

❮ Previous
Next ❯

Software Mentioned

QST

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.